Impact of air pollution on cystic fibrosis pulmonary exacerbations: A case-crossover analysis

Chest

Volumn 143, Issue 4, 2013, Pages 946-954

  Goeminne, Pieter C ^a   Kiciński, Michał ^b   Vermeulen, François ^a   Fierens, Frans ^c   De Boeck, Kris ^a   Nemery, Benoit ^d   Nawrot, Tim S ^b,d   Dupont, Lieven J ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UHasselt   (Belgium)

^c Belgian Interregional Environment Agency   (Belgium)

^d UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; NITROGEN DIOXIDE;

ADULT; AIR POLLUTION; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE EXACERBATION; DRUG USE; ENVIRONMENTAL EXPOSURE; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH CARE COST; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; OZONE LAYER; PARTICLE SIZE; PARTICULATE MATTER; PRIORITY JOURNAL; QUALITY OF LIFE; TEMPERATURE MEASUREMENT;

EID: 84875987580     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-1005     Document Type: Article

References (45)

1. Wheeler BW, Ben-Shlomo Y. Environmental equity, air quality, socioeconomic status, and respiratory health: a linkage analysis of routine data from the Health Survey for England. J Epidemiol Community Health. 2005; 59 (11): 948 - 954.
2. Gauderman WJ, Avol E, Gilliland F, et al. The effect of air pollution on lung development from 10 to 18 years of age. N Engl J Med. 2004; 351 (11): 1057 - 1067.
3. Kulkarni N, Pierse N, Rushton L, Grigg J. Carbon in airway macrophages and lung function in children. N Engl J Med. 2006; 355 (1): 21 - 30.
4. Neupane B, Jerrett M, Burnett RT, Marrie T, Arain A, Loeb M. Long-term exposure to ambient air pollution and risk of hospitalization with community-acquired pneumonia in older adults. Am J Respir Crit Care Med. 2010; 181 (1): 47 - 53.
5. Peacock JL, Anderson HR, Bremner SA, et al. Outdoor air pollution and respiratory health in patients with COPD. Thorax. 2011; 66 (7): 591 - 596.
6. McCreanor J, Cullinan P, Nieuwenhuijsen MJ, et al. Respiratory effects of exposure to diesel traffic in persons with asthma. N Engl J Med. 2007; 357 (23): 2348 - 2358.
7. Kamdar O, Le W, Zhang J, Ghio AJ, Rosen GD, Upadhyay D. Air pollution induces enhanced mitochondrial oxidative stress in cystic fibrosis airway epithelium. FEBS Lett. 2008; 582 (25-26): 3601 - 3606.
8. Goss CH, Newsom SA, Schildcrout JS, Sheppard L, Kaufman JD. Effect of ambient air pollution on pulmonary exacerbations and lung function in cystic fibrosis. Am J Respir Crit Care Med. 2004; 169 (7): 816 - 821.
9. Britto MT, Kotagal UR, Hornung RW, Atherton HD, Tsevat J, Wilmott RW. Impact of recent pulmonary exacerbations on quality of life in patients with cystic fibrosis. Chest. 2002; 121 (1): 64 - 72.
10. Dobbin CJ, Bartlett D, Melehan K, Grunstein RR, Bye PT. The effect of infective exacerbations on sleep and neurobehavioral function in cystic fibrosis. Am J Respir Crit Care Med. 2005; 172 (1): 99 - 104.
11. Goldbeck L, Zerrer S, Schmitz TG. Monitoring quality of life in outpatients with cystic fibrosis: feasibility and longitudinal results. J Cyst Fibros. 2007; 6 (3): 171 - 178.
12. Robson M, Abbott J, Webb K, Dodd M, Walsworth-Bell J. A cost description of an adult cystic fibrosis unit and cost analyses of different categories of patients. Thorax. 1992; 47(9): 684- 689.
13. Sanders DB, Bittner RC, Rosenfeld M, Hoffman LR, Redding GJ, Goss CH. Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation. Am J Respir Crit Care Med. 2010; 182 (5): 627 - 632.
14. Sanders DB, Bittner RC, Rosenfeld M, Redding GJ, Goss CH. Pulmonary exacerbations are associated with subsequent FEV 1 decline in both adults and children with cystic fibrosis. Pediatr Pulmonol. 2011; 46 (4): 393 - 400.
15. Bilton D, Canny G, Conway S, et al. Pulmonary exacerbation: towards a definition for use in clinical trials. Report from the EuroCareCF Working Group on outcome parameters in clinical trials. J Cyst Fibros. 2011; 10 (suppl 2): S79 - S81.
16. Fuchs HJ, Borowitz DS, Christiansen DH, et al The Pulmozyme Study Group. Effect of aerosolized recombinant human DN ase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. N Engl J Med. 1994; 331 (10): 637 - 642.
17. Lee TW, Brownlee KG, Conway SP, Denton M, Little wood JM. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros. 2003; 2 (1): 29 - 34.
18. Jacobs L, Emmerechts J, Mathieu C, et al. Air pollution related prothrombotic changes in persons with diabetes. Environ Health Perspect. 2010; 118 (2): 191 - 196.
19. Janssen S, Dumont G, Fierens F, Mensink C. Spatial interpolation of air pollution measurements using CORINE land cover data. Atmos Environ. 2011; 42 (20): 4884 - 4903.
20. Nawrot TS, Perez L, Künzli N, Munters E, Nemery B. Public health importance of triggers of myocardial infarction: a comparative risk assessment. Lancet. 2011; 377(9767): 732- 740.
21. Scheers H, Mwalili SM, Faes C, Fierens F, Nemery B, Nawrot TS. Does air pollution trigger infant mortality in Western Europe? A case-crossover study. Environ Health Perspect. 2011; 119 (7): 1017 - 1022.
22. Maclure M. The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol. 1991; 133 (2): 144 - 153.
23. Navidi W. Bidirectional case-crossover designs for exposures with time trends. Biometrics. 1998; 54 (2): 596 - 605.
24. Janes H, Sheppard L, Lumley T. Overlap bias in the case-crossover design, with application to air pollution exposures. Stat Med. 2005; 24 (2): 285 - 300.
25. Heinzl H, Kaider A. Gaining more flexibility in Cox proportional hazards regression models with cubic spline functions. Comput Methods Programs Biomed. 1997; 54 (3): 201 - 208.
26. Vanderstraeten P, Forton M, Brasseur O, Offer ZY. Black carbon instead of particle mass concentration as an indicator for the traffic related particles in the Brussels capital region. JEP. 2011; 2 : 525 - 532.
27. Krzyzanowski M, Kuna-Dibbert B, Schneider J. Health Effects of Transport-Related Air Pollution. Geneva, Switzerland: World Health Organization; 2005.
28. Cakmak S, Mahmud M, Grgicak-Mannion A, Dales RE. The influence of neighborhood traffic density on the respiratory health of elementary schoolchildren. Environ Int. 2012; 39 (1): 128 - 132.
29. Andersson M, Modig L, Hedman L, Forsberg B, Rönmark E. Heavy vehicle traffic is related to wheeze among schoolchildren: a population-based study in an area with low traffic flows. Environ Health. 2011; 10 : 91.
30. Iskandar A, Andersen ZJ, Bønnelykke K, Ellermann T, Andersen KK, Bisgaard H. Coarse and fine particles but not ultrafine particles in urban air trigger hospital admission for asthma in children. Thorax. 2012; 67 (3): 252 - 257.
31. Oftedal B, Nafstad P, Magnus P, Bjørkly S, Skrondal A. Traffic related air pollution and acute hospital admission for respiratory diseases in Drammen, Norway 1995-2000. Eur J Epidemiol. 2003; 18 (7): 671 - 675.
32. Andersen ZJ, Hvidberg M, Jensen SS, et al. Chronic obstructive pulmonary disease and long-term exposure to trafficrelated air pollution: a cohort study. Am J Respir Crit Care Med. 2011; 183 (4): 455 - 461.
33. Katsouyanni K, Touloumi G, Samoli E, et al. Confounding and effect modification in the short-term effects of ambient particles on total mortality: results from 29 European cities within the APHEA2 project. Epidemiology. 2001; 12 (5): 521 - 531.
34. Tramuto F, Cusimano R, Cerame G, et al. Urban air pollution and emergency room admissions for respiratory symptoms: a case-crossover study in Palermo, Italy. Environ Health. 2011; 10: 31.
35. Nawrot TS, Torfs R, Fierens F, et al. Stronger associations between daily mortality and fine particulate air pollution in summer than in winter: evidence from a heavily polluted region in western Europe. J Epidemiol Community Health. 2007; 61 (2): 146 - 149.
36. Hetland RB, Cassee FR, Låg M, Refsnes M, Dybing E, Schwarze PE. Cytokine release from alveolar macrophages exposed to ambient particulate matter: heterogeneity in relation to size, city and season. Part Fibre Toxicol. 2005; 2 : 4.
37. Ozkaynak H, Xue J, Spengler J, Wallace L, Pellizzari E, Jenkins P. Personal exposure to airborne particles and metals: results from the Particle TEAM study in Riverside, California. J Expo Anal Environ Epidemiol. 1996; 6 (1): 57 - 78.
38. Janssen NA, Hoek G, Brunekreef B, Harssema H, Mensink I, Zuidhof A. Personal sampling of particles in adults: relation among personal, indoor, and outdoor air concentrations. Am J Epidemiol. 1998; 147 (6): 537 - 547.
39. Sørensen M, Loft S, Andersen HV, et al. Personal exposure to PM2.5, black smoke and NO2 in Copenhagen: relationship to bedroom and outdoor concentrations covering seasonal variation. J Expo Anal Environ Epidemiol. 2005; 15 (5): 413 - 422.
40. Collaco JM, McGready J, Green DM, et al ACFBAL Study Group. Effect of temperature on cystic fibrosis lung disease and infections: a replicated cohort study. PLoS ONE. 2011; 6 (11): e27784.
41. Cesaroni G, Boogaard H, Jonkers S, et al. Health benefits of traffic-related air pollution reduction in different socioeconomic groups: the effect of low-emission zoning in Rome. Occup Environ Med. 2012; 69 (2): 133 - 139.
42. Proesmans M, Vermeulen F, Boulanger L, Verhaegen J, De Boeck K. Comparison of two treatment regimens for eradication of Pseudomonas aeruginosa infection in children with cystic fibrosis [Published online ahead of print July 2, 2012]. J Cyst Fibros. 2012. doi: 10.1016/j.jcf.2012.06.001.
43. Brook RD, Rajagopalan S, Pope CA III, et al American Heart Association Council on Epidemiology and Prevention, Council on the Kidney in Cardiovascular Disease, and Council on Nutrition, Physical Activity and Metabolism. Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association. Circulation. 2010; 121 (21): 2331 - 2378.
44. Janssen NA, Lanki T, Hoek G, et al. Associations between ambient, personal, and indoor exposure to fine particulate matter constituents in Dutch and Finnish panels of cardiovascular patients. Occup Environ Med. 2005; 62 (12): 868 - 877.
45. Williams R, Suggs J, Zweidinger R, et al. The 1998 Baltimore Particulate Matter Epidemiology-Exposure Study: part 1. Comparison of ambient, residential outdoor, indoor and apartment particulate matter monitoring. J Expo Anal Environ Epidemiol. 2000; 10 (6 pt 1): 518 - 532.